New ICD-10-CM Codes in
619 codes were added to the 2021 ICD-10-CM code set, effective October 1, 2020.
Displaying codes 1-100 of 619:
-
A84.81 Powassan virus disease
-
A84.89 Other tick-borne viral encephalitis
-
B60.00 Babesiosis, unspecified
-
B60.01 Babesiosis due to Babesia microti
-
B60.02 Babesiosis due to Babesia duncani
-
B60.03 Babesiosis due to Babesia divergens
-
B60.09 Other babesiosis
-
D57.03 Hb-SS disease with cerebral vascular involvement
-
D57.09 Hb-SS disease with crisis with other specified complication
-
D57.213 Sickle-cell/Hb-C disease with cerebral vascular involvement
-
D57.218 Sickle-cell/Hb-C disease with crisis with other specified complication
-
D57.413 Sickle-cell thalassemia, unspecified, with cerebral vascular involvement
-
D57.418 Sickle-cell thalassemia, unspecified, with crisis with other specified complication
-
D57.42 Sickle-cell thalassemia beta zero without crisis
-
D57.43 Sickle-cell thalassemia beta zero with crisis
-
D57.431 Sickle-cell thalassemia beta zero with acute chest syndrome
-
D57.432 Sickle-cell thalassemia beta zero with splenic sequestration
-
D57.433 Sickle-cell thalassemia beta zero with cerebral vascular involvement
-
D57.438 Sickle-cell thalassemia beta zero with crisis with other specified complication
-
D57.439 Sickle-cell thalassemia beta zero with crisis, unspecified
-
D57.44 Sickle-cell thalassemia beta plus without crisis
-
D57.45 Sickle-cell thalassemia beta plus with crisis
-
D57.451 Sickle-cell thalassemia beta plus with acute chest syndrome
-
D57.452 Sickle-cell thalassemia beta plus with splenic sequestration
-
D57.453 Sickle-cell thalassemia beta plus with cerebral vascular involvement
-
D57.458 Sickle-cell thalassemia beta plus with crisis with other specified complication
-
D57.459 Sickle-cell thalassemia beta plus with crisis, unspecified
-
D57.813 Other sickle-cell disorders with cerebral vascular involvement
-
D57.818 Other sickle-cell disorders with crisis with other specified complication
-
D59.10 Autoimmune hemolytic anemia, unspecified
-
D59.11 Warm autoimmune hemolytic anemia
-
D59.12 Cold autoimmune hemolytic anemia
-
D59.13 Mixed type autoimmune hemolytic anemia
-
D59.19 Other autoimmune hemolytic anemia
-
D72.10 Eosinophilia, unspecified
-
D72.11 Hypereosinophilic syndrome [HES]
-
D72.110 Idiopathic hypereosinophilic syndrome [IHES]
-
D72.111 Lymphocytic Variant Hypereosinophilic Syndrome [LHES]
-
D72.118 Other hypereosinophilic syndrome
-
D72.119 Hypereosinophilic syndrome [HES], unspecified
-
D72.12 Drug rash with eosinophilia and systemic symptoms syndrome
-
D72.18 Eosinophilia in diseases classified elsewhere
-
D72.19 Other eosinophilia
-
D84.81 Immunodeficiency due to conditions classified elsewhere
-
D84.82 Immunodeficiency due to drugs and external causes
-
D84.821 Immunodeficiency due to drugs
-
D84.822 Immunodeficiency due to external causes
-
D84.89 Other immunodeficiencies
-
D89.83 Cytokine release syndrome
-
D89.831 Cytokine release syndrome, grade 1
-
D89.832 Cytokine release syndrome, grade 2
-
D89.833 Cytokine release syndrome, grade 3
-
D89.834 Cytokine release syndrome, grade 4
-
D89.835 Cytokine release syndrome, grade 5
-
D89.839 Cytokine release syndrome, grade unspecified
-
E70.81 Aromatic L-amino acid decarboxylase deficiency
-
E70.89 Other disorders of aromatic amino-acid metabolism
-
E74.81 Disorders of glucose transport, not elsewhere classified
-
E74.810 Glucose transporter protein type 1 deficiency
-
E74.818 Other disorders of glucose transport
-
E74.819 Disorders of glucose transport, unspecified
-
E74.89 Other specified disorders of carbohydrate metabolism
-
F10.13 Alcohol abuse, with withdrawal
-
F10.130 Alcohol abuse with withdrawal, uncomplicated
-
F10.131 Alcohol abuse with withdrawal delirium
-
F10.132 Alcohol abuse with withdrawal with perceptual disturbance
-
F10.139 Alcohol abuse with withdrawal, unspecified
-
F10.93 Alcohol use, unspecified with withdrawal
-
F10.930 Alcohol use, unspecified with withdrawal, uncomplicated
-
F10.931 Alcohol use, unspecified with withdrawal delirium
-
F10.932 Alcohol use, unspecified with withdrawal with perceptual disturbance
-
F10.939 Alcohol use, unspecified with withdrawal, unspecified
-
F11.13 Opioid abuse with withdrawal
-
F12.13 Cannabis abuse with withdrawal
-
F13.13 Sedative, hypnotic or anxiolytic abuse with withdrawal
-
F13.130 Sedative, hypnotic or anxiolytic abuse with withdrawal, uncomplicated
-
F13.131 Sedative, hypnotic or anxiolytic abuse with withdrawal delirium
-
F13.132 Sedative, hypnotic or anxiolytic abuse with withdrawal with perceptual disturbance
-
F13.139 Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified
-
F14.13 Cocaine abuse, unspecified with withdrawal
-
F14.93 Cocaine use, unspecified with withdrawal
-
F15.13 Other stimulant abuse with withdrawal
-
F19.13 Other psychoactive substance abuse with withdrawal
-
F19.130 Other psychoactive substance abuse with withdrawal, uncomplicated
-
F19.131 Other psychoactive substance abuse with withdrawal delirium
-
F19.132 Other psychoactive substance abuse with withdrawal with perceptual disturbance
-
F19.139 Other psychoactive substance abuse with withdrawal, unspecified
-
G11.10 Early-onset cerebellar ataxia, unspecified
-
G11.11 Friedreich ataxia
-
G11.19 Other early-onset cerebellar ataxia
-
G40.42 Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
-
G40.83 Dravet syndrome
-
G40.833 Dravet syndrome, intractable, with status epilepticus
-
G40.834 Dravet syndrome, intractable, without status epilepticus
-
G71.20 Congenital myopathy, unspecifed
-
G71.21 Nemaline myopathy
-
G71.22 Centronuclear myopathy
-
G71.220 X-linked myotubular myopathy
-
G71.228 Other centronuclear myopathy
-
G71.29 Other congenital myopathy
